Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2022 Filed Mar 2, 2022 23:00 UTC |
Pitt Justin DEVP and General Counsel
|
Tax withholdingCommon Stock | 17,087 | $10.18 | $173,945.66 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 3 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,932 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:51 UTC |
HAMMONS KEVIN JPresident and CFO
|
GrantStock Options (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-014987 · doc4.xml · derivative · entry 6 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-29 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:51 UTC |
HAMMONS KEVIN JPresident and CFO
|
GrantPerformance Based Restricted · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014987 · doc4.xml · derivative · entry 5 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:51 UTC |
HAMMONS KEVIN JPresident and CFO
|
Exercise / conversionPerformance Based Restricted · Derivative | 18,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014987 · doc4.xml · derivative · entry 4 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:51 UTC |
HAMMONS KEVIN JPresident and CFO
|
Tax withholdingCommon Stock | 32,596 | $10.18 | $331,827.28 |
DisclosureSEC source: 0001209191-22-014987 · doc4.xml · nonDerivative · entry 3 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,357 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:51 UTC |
HAMMONS KEVIN JPresident and CFO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014987 · doc4.xml · nonDerivative · entry 2 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,953 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:51 UTC |
HAMMONS KEVIN JPresident and CFO
|
Exercise / conversionCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014987 · doc4.xml · nonDerivative · entry 1 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:04 UTC |
STOCKTON KEVIN ARegional President
|
GrantStock Options (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-015016 · doc4.xml · derivative · entry 4 STOCKTON KEVIN A · CIK 0001862464 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-02-29 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:04 UTC |
STOCKTON KEVIN ARegional President
|
GrantPerformance Based Restricted · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015016 · doc4.xml · derivative · entry 3 STOCKTON KEVIN A · CIK 0001862464 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:04 UTC |
STOCKTON KEVIN ARegional President
|
Tax withholdingCommon Stock | 6,350 | $10.18 | $64,643.00 |
DisclosureSEC source: 0001209191-22-015016 · doc4.xml · nonDerivative · entry 2 STOCKTON KEVIN A · CIK 0001862464 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,634 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:04 UTC |
STOCKTON KEVIN ARegional President
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015016 · doc4.xml · nonDerivative · entry 1 STOCKTON KEVIN A · CIK 0001862464 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,984 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:03 UTC |
SMITH WAYNE TDirector · Executive Chairman
|
GrantStock Options (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-015013 · doc4.xml · derivative · entry 8 SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2032-02-29 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:03 UTC |
SMITH WAYNE TDirector · Executive Chairman
|
GrantPerformance Based Restricted · Derivative | 180,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015013 · doc4.xml · derivative · entry 7 SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:03 UTC |
SMITH WAYNE TDirector · Executive Chairman
|
Exercise / conversionPerformance Based Restricted · Derivative | 157,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015013 · doc4.xml · derivative · entry 6 SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 157,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:03 UTC |
SMITH WAYNE TDirector · Executive Chairman
|
Tax withholdingCommon Stock | 160,845 | $10.18 | $1,637,402.10 |
DisclosureSEC source: 0001209191-22-015013 · doc4.xml · nonDerivative · entry 3 SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,059,196 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:03 UTC |
SMITH WAYNE TDirector · Executive Chairman
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015013 · doc4.xml · nonDerivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,220,041 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:03 UTC |
SMITH WAYNE TDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 315,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015013 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,130,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:02 UTC |
Simon Lynn TPresident and CMO
|
GrantStock Options (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 6 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-29 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:02 UTC |
Simon Lynn TPresident and CMO
|
GrantPerformance Based Restricted · Derivative | 80,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 5 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:02 UTC |
Simon Lynn TPresident and CMO
|
Exercise / conversionPerformance Based Restricted · Derivative | 52,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 4 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:02 UTC |
Simon Lynn TPresident and CMO
|
Tax withholdingCommon Stock | 53,543 | $10.18 | $545,067.74 |
DisclosureSEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 3 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,884 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:02 UTC |
Simon Lynn TPresident and CMO
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 2 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,427 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:02 UTC |
Simon Lynn TPresident and CMO
|
Exercise / conversionCommon Stock | 105,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 1 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC |
Pitt Justin DEVP and General Counsel
|
GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 8 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-02-29 F5 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC |
Pitt Justin DEVP and General Counsel
|
GrantPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 7 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC |
Pitt Justin DEVP and General Counsel
|
Exercise / conversionPerformance Based Restricted · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 6 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC |
Pitt Justin DEVP and General Counsel
|
Tax withholdingCommon Stock | 1,385 | $10.18 | $14,099.30 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 5 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 15,553 F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC |
Pitt Justin DEVP and General Counsel
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 4 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 16,938 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC |
Pitt Justin DEVP and General Counsel
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 2 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,019 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC |
Pitt Justin DEVP and General Counsel
|
Exercise / conversionCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:57 UTC |
MEDLEY MARK BRegional President
|
GrantStock Options (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-015001 · doc4.xml · derivative · entry 4 MEDLEY MARK B · CIK 0001863028 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-02-29 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:57 UTC |
MEDLEY MARK BRegional President
|
GrantPerformance Based Restricted · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015001 · doc4.xml · derivative · entry 3 MEDLEY MARK B · CIK 0001863028 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:57 UTC |
MEDLEY MARK BRegional President
|
Tax withholdingCommon Stock | 3,936 | $10.18 | $40,068.48 |
DisclosureSEC source: 0001209191-22-015001 · doc4.xml · nonDerivative · entry 2 MEDLEY MARK B · CIK 0001863028 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,709 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:57 UTC |
MEDLEY MARK BRegional President
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015001 · doc4.xml · nonDerivative · entry 1 MEDLEY MARK B · CIK 0001863028 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,645 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:56 UTC |
MASON AUSTEN DRegional President
|
GrantStock Options (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-015000 · doc4.xml · derivative · entry 3 MASON AUSTEN D · CIK 0001863033 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-02-29 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:56 UTC |
MASON AUSTEN DRegional President
|
GrantPerformance Based Restricted · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015000 · doc4.xml · derivative · entry 2 MASON AUSTEN D · CIK 0001863033 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:56 UTC |
MASON AUSTEN DRegional President
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015000 · doc4.xml · nonDerivative · entry 1 MASON AUSTEN D · CIK 0001863033 · Regional President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:55 UTC |
Johnson Jason KSVP & CAO
|
GrantStock Options (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-014997 · doc4.xml · derivative · entry 4 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-02-29 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:55 UTC |
Johnson Jason KSVP & CAO
|
GrantPerformance Based Restricted · Derivative | 25,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014997 · doc4.xml · derivative · entry 3 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:55 UTC |
Johnson Jason KSVP & CAO
|
Tax withholdingCommon Stock | 5,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014997 · doc4.xml · nonDerivative · entry 2 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,945 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:55 UTC |
Johnson Jason KSVP & CAO
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014997 · doc4.xml · nonDerivative · entry 1 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,442 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:54 UTC |
Hingtgen TimDirector · CEO
|
GrantStock Options (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-014993 · doc4.xml · derivative · entry 6 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-29 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:54 UTC |
Hingtgen TimDirector · CEO
|
GrantPerformance Based Restricted · Derivative | 200,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014993 · doc4.xml · derivative · entry 5 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:54 UTC |
Hingtgen TimDirector · CEO
|
Exercise / conversionPerformance Based Restricted · Derivative | 112,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014993 · doc4.xml · derivative · entry 4 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:54 UTC |
Hingtgen TimDirector · CEO
|
Tax withholdingCommon Stock | 118,872 | $10.18 | $1,210,116.96 |
DisclosureSEC source: 0001209191-22-014993 · doc4.xml · nonDerivative · entry 3 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 736,178 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:54 UTC |
Hingtgen TimDirector · CEO
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014993 · doc4.xml · nonDerivative · entry 2 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855,050 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:54 UTC |
Hingtgen TimDirector · CEO
|
Exercise / conversionCommon Stock | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014993 · doc4.xml · nonDerivative · entry 1 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 755,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:48 UTC |
Williams Hubert JamesDirector
|
GrantRestricted Stock Units · Derivative | 17,682 | $10.18 Strike: $0.00 | $180,002.76 |
DisclosureSEC source: 0001209191-22-014984 · doc4.xml · derivative · entry 3 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,682 Underlying: Common Stock · 17,682 shares Expires not disclosed F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:48 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014984 · doc4.xml · derivative · entry 2 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. F2 · derivative.expiration_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:48 UTC |
Williams Hubert JamesDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014984 · doc4.xml · nonDerivative · entry 1 Williams Hubert James · CIK 0001659816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.